Viewing Study NCT00527605

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:09 AM
Ignite Modification Date: 2026-02-21 @ 11:18 PM
Study NCT ID: NCT00527605
Status: COMPLETED
Last Update Posted: 2012-03-21
First Post: 2007-09-10
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Dutasteride 0.5mg For The Treatment Of Chinese Patients With Benign Prostatic Hyperplasia (BPH)
Sponsor: GlaxoSmithKline
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Benign Prostatic Hyperplasia View
None Prostatic Hyperplasia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None placebo control View
None Chinese View
None Dutasteride View
None Randomized View
None Benign Prostatic Hyperplasia View
None Double blind View